trending Market Intelligence /marketintelligence/en/news-insights/trending/gUylmT030aW6Vax3lMbpPw2 content esgSubNav
In This List

Novelion Therapeutics adds director; 2 others step down

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Novelion Therapeutics adds director; 2 others step down

Novelion Therapeutics Inc. appointed Mark DiPaolo to its board.

DiPaolo is with Sarissa Capital Management LP as a partner and general counsel.

In addition, Geoffrey Cox and Jorge Plutzky stepped down from the company's board.